Botanix Pharmaceuticals Limited (ASX:BOT)

Botanix Pharmaceuticals Financials Overview

Financials in millions AUD. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue Revenue Growth	21.92	5.79	2.07	3.77	2.75	6.89
Revenue Growth	278.59%	179.74%	-45.14%	36.94%	-60.00%	-9.07%
Gross Profit Gross Profit Growth	13.39	2.02	-1.58	-1.96	-7.54	0.32
Operating Income Operating Income Growth	-84.56	-82.91	-13.99	-9.13	-13.19	-3.38
Net Income Net Income Growth	-88.7	-86.4	-13.87	-9.15	-13.17	-3.33
Earnings Per Share EPS Growth	-0.05	-0.05	-0.01	-0.01	-0.01	-0.00
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023
United States United States Growth	21.92	5.76	0.6	0.1
Australia Australia Growth	-	-	1.54	3.73
Total Total Growth	21.92	5.76	2.15	3.84

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Investments Cash & Investments Growth	31.61	64.97	79.31	10.25	7.29	21.55
Total Debt Total Debt Growth	1.08	1.22	-	-	0.12	0.26
Net Cash (Debt) Net Cash Growth	30.53	63.75	79.31	10.25	7.16	21.3
Net Cash Growth	-52.10%	-19.62%	673.71%	43.10%	-66.36%	-12.09%
Net Cash Per Share Net Cash Per Share Growth	0.02	0.03	0.05	0.01	0.01	0.02

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Cash Flow Operating Cash Flow Growth	-78.29	-78.58	-8.13	-12.07	-11.18	-2.97
Capital Expenditures CapEx Growth	-0.2	-0.29	-0.11	-0.01	-0.01	-0.01
Free Cash Flow Free Cash Flow Growth	-78.49	-78.87	-8.24	-12.08	-11.19	-2.98
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Gross Margin	61.11%	34.85%	-76.48%	-51.83%	-273.62%	4.58%
Operating Margin	-385.82%	-1432.24%	-676.11%	-241.93%	-478.66%	-49.08%
Pretax Margin	-404.72%	-1492.37%	-670.20%	-242.66%	-478.10%	-48.41%
Profit Margin	-404.72%	-1492.37%	-670.20%	-242.66%	-478.10%	-48.41%
FCF Margin	-358.13%	-1362.39%	-398.17%	-320.27%	-406.24%	-43.21%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Forward PE	-	86.00	69.00	6.25	6.25	6.25
PS Ratio	2.37	108.40	301.75	45.23	20.14	11.30

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 1, 2026

Data Sources Report a data error